These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21211967)

  • 1. Compounds containing 2-substituted imidazole ring for treatment against human African trypanosomiasis.
    Samant BS; Sukhthankar MG
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1015-8. PubMed ID: 21211967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents.
    Ohkanda J; Buckner FS; Lockman JW; Yokoyama K; Carrico D; Eastman R; de Luca-Fradley K; Davies W; Croft SL; Van Voorhis WC; Gelb MH; Sebti SM; Hamilton AD
    J Med Chem; 2004 Jan; 47(2):432-45. PubMed ID: 14711313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
    Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
    Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis.
    Hwang JY; Smithson D; Connelly M; Maier J; Zhu F; Guy KR
    Bioorg Med Chem Lett; 2010 Jan; 20(1):149-52. PubMed ID: 19963377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new S-adenosylmethionine decarboxylase inhibitors for the treatment of Human African Trypanosomiasis (HAT).
    Hirth B; Barker RH; Celatka CA; Klinger JD; Liu H; Nare B; Nijjar A; Phillips MA; Sybertz E; Willert EK; Xiang Y
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2916-9. PubMed ID: 19419862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites.
    Baliani A; Bueno GJ; Stewart ML; Yardley V; Brun R; Barrett MP; Gilbert IH
    J Med Chem; 2005 Aug; 48(17):5570-9. PubMed ID: 16107157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and development of the 1,4-benzodiazepin-2-one and quinazoline-2,4-dione scaffolds as submicromolar inhibitors of HAT.
    Clark RL; Clements CJ; Barrett MP; Mackay SP; Rathnam RP; Owusu-Dapaah G; Spencer J; Huggan JK
    Bioorg Med Chem; 2012 Oct; 20(20):6019-33. PubMed ID: 22985960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
    Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H
    J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis.
    Tatipaka HB; Gillespie JR; Chatterjee AK; Norcross NR; Hulverson MA; Ranade RM; Nagendar P; Creason SA; McQueen J; Duster NA; Nagle A; Supek F; Molteni V; Wenzler T; Brun R; Glynne R; Buckner FS; Gelb MH
    J Med Chem; 2014 Feb; 57(3):828-35. PubMed ID: 24354316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
    Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
    Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of bioactive 1,2-annulated adamantane derivatives.
    Zoidis G; Tsotinis A; Kolocouris N; Kelly JM; Prathalingam SR; Naesens L; De Clercq E
    Org Biomol Chem; 2008 Sep; 6(17):3177-85. PubMed ID: 18698478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness.
    Smith TK; Crossman A; Brimacombe JS; Ferguson MA
    EMBO J; 2004 Nov; 23(23):4701-8. PubMed ID: 15526036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a series of N6-substituted adenosines with activity against trypanosomatid parasites.
    Link A; Heidler P; Kaiser M; Brun R
    Eur J Med Chem; 2009 Sep; 44(9):3665-71. PubMed ID: 19285758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel microwave synthesis of quinoline-3-carboxylic acid derivatives for treatment against human African trypanosomiasis.
    Samant BS; Nyangari N
    Mol Divers; 2012 Nov; 16(4):685-95. PubMed ID: 23054534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylactic and curative action of Ridzol-S and Ronidazole in experimental trypanosomiasis caused by Trypanosoma brucei et T. evansi].
    Tchalim TK
    Ann Soc Belg Med Trop; 1980 Sep; 60(3):263-70. PubMed ID: 7195691
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
    Nwodo NJ; Brun R; Osadebe PO
    J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
    Jones AJ; Kaiser M; Avery VM
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.